Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Topic or Issue
Home Search/Browse Subscriptions PDA Services My JCO Customer Service

Journal of Clinical Oncology, 2008 ASCO Annual Meeting Proceedings (Post-Meeting Edition).
Vol 26, No 15S (May 20 Supplement), 2008: 500
© 2008 American Society of Clinical Oncology
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bernard, J. R.
Right arrow Articles by Perez, E. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bernard, J. R., Jr.
Right arrow Articles by Perez, E. A.

Abstract

Mammographically occult contralateral breast carcinoma detected by magnetic resonance imaging in the elderly

J. R. Bernard, Jr., L. A. Vallow, E. R. DePeri, D. G. Feigel, S. Amar, S. J. Buskirk and E. A. Perez

Mayo Clinic, Jacksonville, FL

500

Background: Magnetic resonance imaging (MRI) may be able to detect clinically and mammographically occult contralateral breast carcinoma in 3.1% of newly diagnosed breast cancer patients (Lehman CD, et al. N Engl J Med 2007;356:1295–303). Breast cancer incidence has been shown to have a strong correlation with patient age. The incidence of mammographically occult contralateral breast cancer detected by MRI in women with newly diagnosed breast carcinoma in patients > 70 was assessed at our institution. Methods: Between 7/2003 and 07/2007, 159 women age > 70 with pathologically confirmed, newly diagnosed breast cancer were identified from an IRB approved MRI database. Patients noted to have a synchronous contralateral abnormality identified by MRI, but not evident on mammography or clinical examination, were reviewed. Those patients in which biopsy was recommended and performed were further analyzed to determine the incidence of pathologically diagnosed contralateral carcinoma. Results: The median age at diagnosis was 75 (range = 70–91). Mammographically occult contralateral breast abnormalities were described in 65 (41%). Of those women with a contralateral abnormality, biopsy was performed in 28 (43%). Of the women who underwent a biopsy, 9 (32%) had pathologically confirmed carcinoma, whereas 19 (68%) women had other benign diagnoses. Five patients were found to have invasive carcinoma and 4 patients were diagnosed with ductal carcinoma in situ. The overall incidence of mammographically occult contralateral carcinoma in our elderly patient population was 5.7% (9/159). The sensitivity, specificity, positive predictive value, and negative predictive value of MRI were 100%, 87%, 32%, and 100%, respectively. Conclusions: The Mayo Clinic Jacksonville experience suggests that up to 5.7% of newly diagnosed elderly breast cancer patients may have a clinically and mammographically occult carcinoma detected by MRI. Older age should not be a deterrent to obtaining breast MRI and in fact, because of the higher tendency to have a contralateral carcinoma, should be considered. Further study in the use of MRI for screening in this population is needed for corroboration.

No significant financial relationships to disclose.

Abstract presentation from the 2008 ASCO Annual Meeting




About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions

Copyright © 2008 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
HighWire Press HighWire Press™ assists in the publication of JCO Online